Financial Partners Group (Kansas)’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.1M | Buy |
1,192
+32
| +3% | +$32.4K | 0.13% | 84 |
|
|
2025
Q4 | $1.2M | Buy |
1,160
+64
| +6% | +$61.2K | 0.14% | 80 |
|
|
2025
Q3 | $836K | Buy |
1,096
+84
| +8% | +$62.5K | 0.1% | 89 |
|
|
2025
Q2 | $789K | Buy |
1,012
+9
| +0.9% | +$6.99K | 0.11% | 86 |
|
|
2025
Q1 | $829K | Buy |
1,003
+1
| +0.1% | +$832 | 0.13% | 80 |
|
|
2024
Q4 | $774K | Sell |
1,002
-21
| -2% | -$17.4K | 0.11% | 79 |
|
|
2024
Q3 | $907K | Buy |
1,023
+48
| +5% | +$43.2K | 0.13% | 79 |
|
|
2024
Q2 | $883K | Sell |
975
-14
| -1% | -$11.2K | 0.14% | 75 |
|
|
2024
Q1 | $770K | Sell |
989
-76
| -7% | -$54.1K | 0.12% | 78 |
|
|
2023
Q4 | $621K | Sell |
1,065
-14
| -1% | -$8.17K | 0.11% | 80 |
|
|
2023
Q3 | $638K | Sell |
1,079
-40
| -4% | -$20.6K | 0.13% | 73 |
|
|
2023
Q2 | $503K | Sell |
1,119
-68
| -6% | -$28.5K | 0.1% | 89 |
|
|
2023
Q1 | $408K | Buy |
1,187
+10
| +0.8% | +$3.37K | 0.09% | 97 |
|
|
2022
Q4 | $413K | Sell |
1,177
-136
| -10% | -$48.2K | 0.09% | 101 |
|
|
2022
Q3 | $425K | Buy |
1,313
+52
| +4% | +$16.5K | 0.11% | 89 |
|
|
2022
Q2 | $409K | Buy |
1,261
+2
| +0.2% | +$600 | 0.1% | 93 |
|
|
2022
Q1 | $361K | Buy |
1,259
+39
| +3% | +$10K | 0.08% | 119 |
|
|
2021
Q4 | $299K | Buy |
1,220
+219
| +22% | +$55.5K | 0.07% | 134 |
|
|
2021
Q3 | $231K | Buy |
1,001
+1
| +0.1% | +$247 | 0.05% | 147 |
|
|
2021
Q2 | $229K | Buy |
+1,000
| New | +$201K | 0.06% | 136 |
|
|
2021
Q1 | – | Sell |
-996
| Closed | -$202K | – | 144 |
|
|
2020
Q4 | $202K | Buy |
+996
| New | +$149K | 0.06% | 126 |
|
Other funds holding LLY
VCM
VPM
